Thus, exploring the mechanism of action of the most commonly used glucocorticoid, DEX, on TAM resistant BC cells may provide important insights regarding possible synergistic effect on resistant cells by interfering with E2F3/SOX-2/Wnt signaling. The gene discussed is E2F3; the disease is breast cancer.